McMaster spinout Allarta Life Science wins US$3M to advance cell‑therapy capsules for Type 1 diabetes
Breakthrough T1D awards US$3 million to Allarta Life Science (co‑founded at McMaster) to fund preclinical work and first‑in‑human trials of LifeSpheres, hydrogel capsules protecting insulin‑producing cells from immune attack.
Allarta Life Science — co‑founded in 2019 by McMaster chemistry professor Harald Stover and Maria Antonakos, with McMaster as the company’s first shareholder — secured a US$3 million grant from Breakthrough T1D. The financing will support advancement of LifeSpheres hydrogel capsule technology through preclinical studies and toward initial human trials, aiming for a cell therapy that avoids systemic immune suppression. The award was revealed at McMaster’s Innovation Showcase on 17 Nov 2026, highlighting campus pathways from discovery to commercialization.
Read the original story · McMaster University — https://news.mcmaster.ca/2026-innovation-showcase-celebrates-the-people-startups-ideas-driving-innovation/